Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)

v3.23.1
Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]    
Total revenue, net $ 122,647 $ 79,042
Diagnostic services    
Product Information [Line Items]    
Total revenue, net 108,329 68,559
Contract manufacturing    
Product Information [Line Items]    
Total revenue, net 8,740 5,786
Retail and others    
Product Information [Line Items]    
Total revenue, net 1,281 2,454
Genomic products and services    
Product Information [Line Items]    
Total revenue, net $ 4,297 $ 2,243